Prophylactic PEG-rhG-CSF During cCRT in LA-NSCLC

NCT06958614 · clinicaltrials.gov ↗

COMPLETED

Status

213

Enrollment

OTHER

Sponsor class

Conditions

Stage II-III Non-small Cell Lung Cancer
Concurrent Chemotherapy
Conditions Influencing Health Status

Interventions

DRUG: Primary Prophylactic Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences